[Federal Register Volume 84, Number 76 (Friday, April 19, 2019)]
[Notices]
[Page 16461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07908]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-71-2018]


Foreign-Trade Zone (FTZ) 230--Greensboro, North Carolina; 
Authorization of Production Activity; Patheon Softgels (Pharmaceutical 
Products), High Point, North Carolina

    On November 7, 2018, The Piedmont Triad Partnership, grantee of FTZ 
230, submitted a notification of proposed production activity to the 
FTZ Board on behalf of Patheon Softgels, within Subzone 230C in High 
Point, North Carolina.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (83 FR 57409, November 15, 2018). On 
April 16, 2019, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: April 16, 2019.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2019-07908 Filed 4-18-19; 8:45 am]
 BILLING CODE 3510-DS-P